BMY - Bristol-Myers Squibb Company
NEXT EARNINGS:
Apr 30, 2026
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$61.60
DETAILS
HIGH:
$75.00
LOW:
$40.00
MEDIAN:
$62.50
CONSENSUS:
$61.60
UPSIDE:
1.55%
Market Cap:
123.53B
Volume:
9,598,102
Avg Volume:
14,587,433
52 Week Range:
42.52-63.33
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Beta:
0.29
Last Dividend:
$2.49
Exchange:
NYSE
Country:
US
Employees:
34,100
IPO Date:
1972-06-01
EPS (TTM):
3.46
P/E Ratio:
15.61
Revenue (TTM):
48.19B
Total Assets:
90.04B
Total Debt:
47.14B
Cash & Equiv:
10.21B
Rev Growth (5Y):
2.5%
EPS Growth (5Y):
2.9%
FCF Growth (5Y):
-0.7%
ROCE:
16.0%
Debt/Equity:
2.55
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 48.19B | 48.30B | 45.01B | 46.16B | 46.38B | 42.52B | 26.14B | 22.56B | 20.78B | 19.43B | 16.56B | 15.88B |
| Net Income | 7.05B | (8.95B) | 8.03B | 6.33B | 6.99B | (8.99B) | 3.44B | 4.92B | 1.01B | 4.46B | 1.56B | 2.00B |
| EPS | 3.46 | -4.41 | 3.88 | 2.97 | 3.15 | -3.98 | 2.02 | 3.03 | 0.61 | 2.67 | 0.97 | 1.21 |
| Total Assets | 90.04B | 92.60B | 95.16B | 96.82B | 109.31B | 118.48B | 129.94B | 34.99B | 33.55B | 33.71B | 31.75B | 33.75B |
| Total Debt | 47.14B | 51.20B | 41.46B | 40.72B | 45.60B | 51.67B | 47.54B | 7.35B | 7.96B | 6.71B | 6.69B | 7.83B |
| Cash & Equivalents | 10.21B | 10.35B | 11.46B | 9.12B | 13.98B | 14.55B | 12.35B | 6.91B | 5.42B | 4.24B | 2.38B | 5.57B |
| Operating Cash Flow | 14.16B | 15.19B | 13.86B | 13.07B | 16.21B | 14.05B | 8.21B | 7.07B | 5.28B | 3.06B | 2.10B | 3.15B |
| Free Cash Flow | 12.85B | 13.94B | 12.65B | 11.95B | 15.23B | 13.30B | 7.37B | 6.12B | 4.22B | 1.84B | 1.28B | 2.62B |
| FCF per Share | 6.29 | 6.88 | 6.11 | 5.61 | 6.86 | 5.89 | 4.32 | 3.74 | 2.57 | 1.10 | 0.77 | 1.58 |
| Book Value | 18.47B | 16.34B | 29.43B | 31.06B | 35.95B | 37.82B | 51.60B | 14.03B | 11.74B | 16.18B | 14.27B | 14.85B |
| Cash & ST Investments | 10.67B | 10.86B | 12.28B | 9.25B | 17.22B | 16.45B | 15.39B | 8.76B | 6.81B | 6.35B | 4.27B | 7.43B |
| ROC Equity | 0.38 | -0.55 | 0.27 | 0.20 | 0.19 | -0.24 | 0.07 | 0.35 | 0.09 | 0.28 | 0.11 | 0.13 |